List of Tables
    Table 1. Influenza Drugs and Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Influenza Drugs and Vaccines Market Trends
    Table 3. Influenza Drugs and Vaccines Market Drivers
    Table 4. Influenza Drugs and Vaccines Market Challenges
    Table 5. Influenza Drugs and Vaccines Market Restraints
    Table 6. Global Influenza Drugs and Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Influenza Drugs and Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Influenza Drugs and Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Influenza Drugs and Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Influenza Drugs and Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Influenza Drugs and Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Influenza Drugs and Vaccines Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Influenza Drugs and Vaccines Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Influenza Drugs and Vaccines Sales Share by Manufacturer, 2017-2022
    Table 15. Global Influenza Drugs and Vaccines Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2021)
    Table 18. Top Players of Influenza Drugs and Vaccines in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Influenza Drugs and Vaccines Product Type
    Table 20. Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Influenza Drugs and Vaccines Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Influenza Drugs and Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Influenza Drugs and Vaccines Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Influenza Drugs and Vaccines Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Influenza Drugs and Vaccines Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Influenza Drugs and Vaccines Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Influenza Drugs and Vaccines Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Influenza Drugs and Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Influenza Drugs and Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Influenza Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Influenza Drugs and Vaccines Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Influenza Drugs and Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Influenza Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Influenza Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Influenza Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bristol Myers Squibb Corporation Information
    Table 43. Bristol Myers Squibb Description and Business Overview
    Table 44. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. Bristol Myers Squibb Influenza Drugs and Vaccines Product
    Table 46. Bristol Myers Squibb Recent Development
    Table 47. AstraZeneca Corporation Information
    Table 48. AstraZeneca Description and Business Overview
    Table 49. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. AstraZeneca Product
    Table 51. AstraZeneca Recent Development
    Table 52. Eli Lilly Corporation Information
    Table 53. Eli Lilly Description and Business Overview
    Table 54. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Eli Lilly Product
    Table 56. Eli Lilly Recent Development
    Table 57. Roche Corporation Information
    Table 58. Roche Description and Business Overview
    Table 59. Roche Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. Roche Product
    Table 61. Roche Recent Development
    Table 62. GlaxoSmithKline Corporation Information
    Table 63. GlaxoSmithKline Description and Business Overview
    Table 64. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. GlaxoSmithKline Product
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Novartis Corporation Information
    Table 68. Novartis Description and Business Overview
    Table 69. Novartis Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Novartis Product
    Table 71. Novartis Recent Development
    Table 72. Pfizer Corporation Information
    Table 73. Pfizer Description and Business Overview
    Table 74. Pfizer Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. Pfizer Product
    Table 76. Pfizer Recent Development
    Table 77. Sanofi Pasteur Corporation Information
    Table 78. Sanofi Pasteur Description and Business Overview
    Table 79. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. Sanofi Pasteur Product
    Table 81. Sanofi Pasteur Recent Development
    Table 82. Bayer Corporation Information
    Table 83. Bayer Description and Business Overview
    Table 84. Bayer Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 85. Bayer Product
    Table 86. Bayer Recent Development
    Table 87. Celgene Corporation Information
    Table 88. Celgene Description and Business Overview
    Table 89. Celgene Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 90. Celgene Product
    Table 91. Celgene Recent Development
    Table 92. Seqirus Corporation Information
    Table 93. Seqirus Description and Business Overview
    Table 94. Seqirus Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 95. Seqirus Product
    Table 96. Seqirus Recent Development
    Table 97. Protein Sciences Corporation Corporation Information
    Table 98. Protein Sciences Corporation Description and Business Overview
    Table 99. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 100. Protein Sciences Corporation Product
    Table 101. Protein Sciences Corporation Recent Development
    Table 102. Serum Institute of India Corporation Information
    Table 103. Serum Institute of India Description and Business Overview
    Table 104. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 105. Serum Institute of India Product
    Table 106. Serum Institute of India Recent Development
    Table 107. Emergent Biosolutions Corporation Information
    Table 108. Emergent Biosolutions Description and Business Overview
    Table 109. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 110. Emergent Biosolutions Product
    Table 111. Emergent Biosolutions Recent Development
    Table 112. BioCryst Pharmaceuticals Corporation Information
    Table 113. BioCryst Pharmaceuticals Description and Business Overview
    Table 114. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 115. BioCryst Pharmaceuticals Product
    Table 116. BioCryst Pharmaceuticals Recent Development
    Table 117. Alvogen Corporation Information
    Table 118. Alvogen Description and Business Overview
    Table 119. Alvogen Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 120. Alvogen Product
    Table 121. Alvogen Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Influenza Drugs and Vaccines Customers List
    Table 125. Influenza Drugs and Vaccines Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Drugs and Vaccines Product Picture
    Figure 2. Global Influenza Drugs and Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Influenza Drugs and Vaccines Market Size 2017-2028 (US$ Million)
    Figure 4. Global Influenza Drugs and Vaccines Sales 2017-2028 (MT)
    Figure 5. United States Influenza Drugs and Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Influenza Drugs and Vaccines Market Size 2017-2028 (US$ Million)
    Figure 7. United States Influenza Drugs and Vaccines Sales 2017-2028 (MT)
    Figure 8. United States Influenza Drugs and Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Influenza Drugs and Vaccines Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Influenza Drugs and Vaccines Report Years Considered
    Figure 11. Product Picture of Influenza Drugs
    Figure 12. Product Picture of Influenza Vaccines
    Figure 13. Global Influenza Drugs and Vaccines Market Share by Type in 2022 & 2028
    Figure 14. Global Influenza Drugs and Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Influenza Drugs and Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Influenza Drugs and Vaccines Sales by Type (2017-2028) & (MT)
    Figure 17. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Influenza Drugs and Vaccines Price by Type (2017-2028) & (USD/Kg)
    Figure 19. United States Influenza Drugs and Vaccines Market Share by Type in 2022 & 2028
    Figure 20. United States Influenza Drugs and Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Influenza Drugs and Vaccines Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Influenza Drugs and Vaccines Sales by Type (2017-2028) & (MT)
    Figure 23. United States Influenza Drugs and Vaccines Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Influenza Drugs and Vaccines Price by Type (2017-2028) & (USD/Kg)
    Figure 25. Product Picture of Hospital Pharmacy
    Figure 26. Product Picture of Retail Pharmacy
    Figure 27. Product Picture of Online Pharmacy
    Figure 28. Global Influenza Drugs and Vaccines Market Share by Application in 2022 & 2028
    Figure 29. Global Influenza Drugs and Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Influenza Drugs and Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Influenza Drugs and Vaccines Sales by Application (2017-2028) & (MT)
    Figure 32. Global Influenza Drugs and Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Influenza Drugs and Vaccines Price by Application (2017-2028) & (USD/Kg)
    Figure 34. United States Influenza Drugs and Vaccines Market Share by Application in 2022 & 2028
    Figure 35. United States Influenza Drugs and Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Influenza Drugs and Vaccines Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Influenza Drugs and Vaccines Sales by Application (2017-2028) & (MT)
    Figure 38. United States Influenza Drugs and Vaccines Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Influenza Drugs and Vaccines Price by Application (2017-2028) & (USD/Kg)
    Figure 40. North America Influenza Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 41. North America Influenza Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Influenza Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 45. Europe Influenza Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Influenza Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 52. Asia-Pacific Influenza Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Influenza Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 64. Latin America Influenza Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Influenza Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 69. Middle East & Africa Influenza Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Influenza Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Influenza Drugs and Vaccines Value Chain
    Figure 74. Influenza Drugs and Vaccines Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed